Affiliation:
1. State University of New York Upstate Medical University, Syracuse, USA
Abstract
The occurrence of hemolytic anemia in patients with active SARS-CoV-2 infection has been documented in medical literature. While relatively uncommon, there have been instances where this condition presents as a Coombs-negative hemolytic anemia. In this research study, we report a distinctive case of Coombs-negative hemolytic anemia and thrombocytopenia in a patient with a known history of COVID-19 infection. The patient demonstrated a favorable response to treatment involving the administration of steroids and intravenous immunoglobulin (IVIG) therapy. This case adds to the existing body of evidence regarding the hematological manifestations of SARS-CoV-2 infection, highlighting the importance of considering and managing hematological complications in patients with COVID-19.
Subject
Safety Research,Safety, Risk, Reliability and Quality,Epidemiology
Reference13 articles.
1. US Department of Health & Human Services, Centers for Disease Control and Prevention. About COVID-19. Published 2023. Accessed August 18, 2023. https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19.html
2. Coombs‐negative hemolytic anemia in a male with COVID‐19
3. Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19
4. The Impact of COVID-19 Disease on Platelets and Coagulation